Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
This study is an open-label trial of trihexyphenidyl in children with upper extremity
dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to
0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of
upper extremity function.
Phase:
Phase 2
Details
Lead Sponsor:
University of Southern California
Collaborators:
Crowley Carter Foundation Don and Linda Carter Foundation United Cerebral Palsy Foundation